Literature DB >> 15030836

Occurrence and progression of diabetic retinopathy after phacoemulsification cataract surgery.

David Hauser1, Haia Katz, Russell Pokroy, Amir Bukelman, Edna Shechtman, Ayala Pollack.   

Abstract

PURPOSE: To evaluate the risk factors associated with the occurrence and progression of diabetic retinopathy (DR) after phacoemulsification cataract surgery.
SETTING: Department of Ophthalmology, Kaplan Medical Center, Rehovot, Israel.
METHODS: The medical charts of 52 eyes of 48 consecutive patients who had phacoemulsification were retrospectively reviewed. The occurrence of DR (new development of any DR) and progression (DR requiring laser treatment) were correlated with patients' age, sex, duration of diabetes, control of diabetes, hypertension, ischemic heart disease, and surgical technique. Exclusion criteria were significant ocular conditions and a follow-up shorter than 6 months.
RESULTS: The occurrence of DR was associated with male sex, and among males, with the duration of the disease. An analysis including all patients showed that postoperative progression of preexisting DR was not associated with any factor except poor blood sugar control. Neither the occurrence nor progression of DR was associated with reduced visual acuity
CONCLUSIONS: The occurrence and progression of DR after phacoemulsification were associated with different factors. Poor systemic control of diabetes increases the risk.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15030836     DOI: 10.1016/S0886-3350(03)00579-0

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  6 in total

1.  Does diabetic retinopathy increase the incidence of intraoperative complications of phacoemulsification surgery?

Authors:  Arsen Akinci; Cosar Batman; Orhan Zilelioglu
Journal:  Int Ophthalmol       Date:  2007-02-23       Impact factor: 2.031

2.  Posterior capsule opacification and neovascularization treated with intravitreal bevacizumab and Nd:YAG capsulotomy.

Authors:  Grimelda Yuriana Sánchez-Castro; Alejandra Hitos-Fájer; Erick Mendoza-Schuster; Raul Velez-Montoya; Cecilio Francisco Velasco-Barona
Journal:  Clin Ophthalmol       Date:  2008-09

3.  Development of diabetic retinopathy after cataract surgery.

Authors:  Chi-Juei Jeng; Yi-Ting Hsieh; Chung-May Yang; Chang-Hao Yang; Cheng-Li Lin; I-Jong Wang
Journal:  PLoS One       Date:  2018-08-22       Impact factor: 3.240

4.  MicroRNA‑4530 suppresses cell proliferation and induces apoptosis by targeting RASA1 in human umbilical vein endothelial cells.

Authors:  Li Jing; Hong Li; Tao Zhang; Jianxin Lu; Lianjin Zhong
Journal:  Mol Med Rep       Date:  2019-03-01       Impact factor: 2.952

5.  Effect of sustained-release long-acting intravitreal dexamethasone implant in patients of non-proliferative diabetic retinopathy undergoing phacoemulsification: A randomized controlled trial.

Authors:  Parul Chawla Gupta; Jagat Ram; M Praveen Kumar; Aniruddha Agarwal; Vishali Gupta; Ramandeep Singh; Reema Bansal; Deeksha Katoch; Mangat R Dogra; Amod Gupta
Journal:  Indian J Ophthalmol       Date:  2021-11       Impact factor: 1.848

6.  Cataracts in diabetic patients: a review article.

Authors:  Mohammad-Ali Javadi; Siamak Zarei-Ghanavati
Journal:  J Ophthalmic Vis Res       Date:  2008-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.